Canada markets closed

Nurosene Health Inc. (MNNDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.28510.0000 (0.00%)
At close: 11:59AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.2851
Open0.2851
BidN/A x N/A
AskN/A x N/A
Day's Range0.2851 - 0.2851
52 Week Range0.2274 - 1.6100
Volume500
Avg. Volume564
Market Cap12.162M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2130
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    NUROSENE APPOINTS INDUSTRY VETERAN DR. LUCA PANI AS CHIEF INNOVATION AND REGULATORY OFFICER

    Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a health tech company focused on delivering innovative AI-based technology solutions, today announced that Dr. Luca Pani has been appointed Chief Innovation and Regulatory Officer.

  • CNW Group

    NUROSENE ANNOUNCES APPOINTMENT OF NEW CFO

    Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on delivering innovative AI-based technology solutions for mental performance and wellness, appoints seasoned financial executive Swapan Kakumanu as Chief Financial Officer.

  • CNW Group

    NUROSENE APPOINTS SEASONED EXECUTIVE JOSH SPIEGEL AS PRESIDENT OF NETRAMARK

    Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on delivering innovative AI-based technology solutions, today announced that seasoned executive Josh Spiegel has been appointed President of NetraMark, a wholly owned subsidiary of Nurosene Health Inc.